Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular disease in SARS‐CoV‐2 infection
Kei Sato, Jane E. Sinclair, Habib Sadeghirad, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 9
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
Daniel W. Kneller, Hui Li, G.N. Phillips, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 93
Long-term mortality following SARS-CoV-2 infection: A national cohort study from Estonia
Anneli Uusküla, Tuuli Jürgenson, Heti Pisarev, et al.
The Lancet Regional Health - Europe (2022) Vol. 18, pp. 100394-100394
Open Access | Times Cited: 50
Design, Synthesis, and Unprecedented Interactions of Covalent Dipeptide-Based Inhibitors of SARS-CoV-2 Main Protease and Its Variants Displaying Potent Antiviral Activity
Philipp Flury, Nadine Krüger, Katharina Sylvester, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Incidence of diseases of the circulatory system in the working-age population of the Ural Federal District in 2012—2022
Aleksandr S. Shastin, Popov Aa, О. М. Хромцова, et al.
Russian Journal of Preventive Medicine (2025) Vol. 28, Iss. 1, pp. 24-24
Closed Access
Transcriptomic profiling of cardiac tissues from SARS‐CoV‐2 patients identifies DNA damage
Arutha Kulasinghe, Ning Liu, Chin Wee Tan, et al.
Immunology (2022) Vol. 168, Iss. 3, pp. 403-419
Open Access | Times Cited: 25
AI-Accelerated Design of Targeted Covalent Inhibitors for SARS-CoV-2
Rajendra P. Joshi, Katherine Schultz, Jesse Wilson, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 5, pp. 1438-1453
Open Access | Times Cited: 13
Exploration of P1 and P4 modifications of nirmatrelvir: Design, synthesis, biological evaluation, and X-ray structural studies of SARS-CoV-2 Mpro inhibitors
Arun K. Ghosh, Monika Yadav, Iddum Satyanarayana, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116132-116132
Closed Access | Times Cited: 3
Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function
Jane E. Sinclair, Courtney Vedelago, Feargal J. Ryan, et al.
Nature Microbiology (2024)
Open Access | Times Cited: 3
COVID-19 and Loneliness among Older Adults: Associations with Mode of Family/Friend Contacts and Social Participation
Namkee G. Choi, Sarah Hammaker, Diana M. DiNitto, et al.
Clinical Gerontologist (2021) Vol. 45, Iss. 2, pp. 390-402
Open Access | Times Cited: 25
Effect of Fucoidan on the Mitochondrial Membrane Potential (ΔΨm) of Leukocytes from Patients with Active COVID-19 and Subjects That Recovered from SARS-CoV-2 Infection
Karina Janice Guadalupe Díaz‐Reséndiz, Carlos Eduardo Covantes‐Rosales, Alma Betsaida Benítez-Trinidad, et al.
Marine Drugs (2022) Vol. 20, Iss. 2, pp. 99-99
Open Access | Times Cited: 17
Cardiovascular symptoms of PASC are associated with trace-level cytokines that affect the function of human pluripotent stem cell derived cardiomyocytes
Jane E. Sinclair, Courtney Vedelago, Feargal J. Ryan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Alterations in Circulating miRNA Levels after Infection with SARS-CoV-2 Could Contribute to the Development of Cardiovascular Diseases: What We Know So Far
Myrtani Pieri, Panayiotis Vayianos, Vicky Nicolaidou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2380-2380
Open Access | Times Cited: 6
Sars‐Cov‐2 Spike Protein‐Induced Damage of hiPSC‐Derived Cardiomyocytes
Xiaochen Huang, Boxin Huang, Yong He, et al.
Advanced Biology (2022) Vol. 6, Iss. 7
Open Access | Times Cited: 11
Isolated Severe Dysphonia as a Presentation of Post-COVID-19 Syndrome
Joanna Jeleniewska, Ewa Niebudek-Bogusz, Jakub Malinowski, et al.
Diagnostics (2022) Vol. 12, Iss. 8, pp. 1839-1839
Open Access | Times Cited: 11
Biomarkers of oxidative stress and inflammation in subjects with COVID-19: Characterization and prognosis of the disease
Paola Mayara Valente Coronel, Indiara Correia Pereira, Denise Caroline Luiz Soares Basilio, et al.
Microbial Pathogenesis (2023) Vol. 184, pp. 106339-106339
Closed Access | Times Cited: 5
Diseases of the circulatory system among the working-age population during the novel coronavirus infection epidemic in the Russian Federation in 2020—2021
Aleksandr S. Shastin, Vladimir G. Panov, Venera G. Gazimova, et al.
Russian Journal of Preventive Medicine (2024) Vol. 27, Iss. 3, pp. 19-19
Closed Access | Times Cited: 1
Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19
Soumyalekshmi Nair, Estefanía Nova‐Lamperti, Gonzalo Labarca, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
High Risk of Heart Tumors after COVID-19
Л. Б. Митрофанова, I. A. Makarov, Э. А. Гончарова, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2087-2087
Open Access | Times Cited: 4
Respiratory Bacterial and Fungal Superinfections During the Third Surge of the COVID-19 Pandemic in Iran
Maryam Mobarak Qamsari, Leyla Sahebi, Mohammad Reaz Salehi, et al.
Microbial Drug Resistance (2023) Vol. 29, Iss. 3, pp. 104-111
Closed Access | Times Cited: 3
The Cardiac Comeback-Beating Stronger: Exploring the Remarkable Resilience of the Heart in COVID-19 Recovery through Cardiac Autonomic Analysis
Sakshi Garg, Preeti Saini, Moattar Raza Rizvi, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1397-1397
Open Access | Times Cited: 3
Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease: room-temperature X-ray and neutron crystallography, binding thermodynamics, and antiviral activity
Daniel W. Kneller, Hui Li, G.N. Phillips, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 5
Overview of the cardio-metabolic impact of the COVID-19 pandemic
Maryam Barkhordarian, Arezoo Behbood, Maryam Ranjbar, et al.
Endocrine (2023) Vol. 80, Iss. 3, pp. 477-490
Open Access | Times Cited: 2
Transcriptomic profiling of cardiac tissues from SARS-CoV-2 patients identifies DNA damage
Arutha Kulasinghe, Ning Liu, Chin Wee Tan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Prevalence of Dysphonia due to COVID-19 Infection
Hassnaa Afifi, Hossam Abd, El Azeem, et al.
The Egyptian Journal of Hospital Medicine (2024) Vol. 95, Iss. 1, pp. 1706-1713
Open Access
Page 1 - Next Page

Scroll to top